Aug. 26 at 9:22 AM
$AEON is still one to watch closely 👀
Nearly 40M shares traded in one session after routinely seeing less than 1M.
Recent 1.15M-share insider buy, no recent insider selling, and the FDA BPD Type 2b pathway remains the key upcoming catalyst.
The big question now: was that massive volume distribution… or the start of a bigger accumulation phase?
If volume comes back and
$AEON reclaims
$0.25–
$0.26, things could get interesting very quickly. 🔥
Watching
$WETO $CIGL $TNXP